| Name | Norco |
|---|---|
| Organization Name | Norco, Inc. |
| Location | 2555 Highway Ste 2e, Kalispell, Montana 59901 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (406) 752-4804 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A review article by researchers at Boston University School of Medicine suggests that epigenetics may be a useful target to stop the growth, spread and relapse of cancer. The findings are published online in Volume 14 of the International Journal of Molecular Science.
Researchers from the UK used EAVE II, an individual-level, national surveillance system, to determine the frequency of COVID-19-related fatalities among fully vaccinated individuals and to define the clinical and demographic characteristics of COVID-19 deaths in fully vaccinated individuals since the beginning of the COVID-19 vaccination program in Scotland.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million."
Merck, known as MSD outside the United States and Canada, and Endocyte Inc., today announced that they have entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide (EC145).
› Verified 9 days ago
| NPI Number | 1649332206 |
| Organization Name | NORCO, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2555 Hwy #2 E, Kalispell, MT 59901 |
| Phone Number | 406-752-4804 |
News Archive
A review article by researchers at Boston University School of Medicine suggests that epigenetics may be a useful target to stop the growth, spread and relapse of cancer. The findings are published online in Volume 14 of the International Journal of Molecular Science.
Researchers from the UK used EAVE II, an individual-level, national surveillance system, to determine the frequency of COVID-19-related fatalities among fully vaccinated individuals and to define the clinical and demographic characteristics of COVID-19 deaths in fully vaccinated individuals since the beginning of the COVID-19 vaccination program in Scotland.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million."
Merck, known as MSD outside the United States and Canada, and Endocyte Inc., today announced that they have entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide (EC145).
› Verified 9 days ago
News Archive
A review article by researchers at Boston University School of Medicine suggests that epigenetics may be a useful target to stop the growth, spread and relapse of cancer. The findings are published online in Volume 14 of the International Journal of Molecular Science.
Researchers from the UK used EAVE II, an individual-level, national surveillance system, to determine the frequency of COVID-19-related fatalities among fully vaccinated individuals and to define the clinical and demographic characteristics of COVID-19 deaths in fully vaccinated individuals since the beginning of the COVID-19 vaccination program in Scotland.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million."
Merck, known as MSD outside the United States and Canada, and Endocyte Inc., today announced that they have entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide (EC145).
› Verified 9 days ago
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 465 Ash Rd, Kalispell, Montana 59901 Phone: (406) 257-2454 | |
Osco Pharmacy #0018 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 900 W Idaho St, Kalispell, Montana 59901 Phone: (406) 257-7556 | |
Walgreens #9242 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 40 W Idaho St, Kalispell, Montana 59901 Phone: (406) 257-0714 | |
Kalispell Medical Equipment Type: Durable Medical Equipment & Medical Supplies Supplier Location: 55 3rd Ave East North, Kalispell, Montana 59901 Phone: (406) 752-6111 | |
The Clinical Pharmacy Type: Long Term Care Pharmacy Location: 200 Conway Dr, Kalispell, Montana 59901 Phone: (406) 761-7600 |